Compare
Family Office of America, Inc. vs QTREX Quantum Ltd. vs Co-Diagnostics, Inc. vs Vivos Inc
| Latest fiscal year | Family Office of America, Inc. FOFA | QTREX Quantum Ltd. QTEX | Co-Diagnostics, Inc. CODX | Vivos Inc RDGL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $221.8K | $289.0K | $622.5K | $68.4K |
| Revenue growth (YoY) | n/a | n/a | -84.1% | +144.3% |
| Gross margin | 100.0% | 0.7% | 64.3% | -87.4% |
| Operating margin | -226.0% | n/m | n/m | n/m |
| Net margin | -222.2% | n/m | n/m | n/m |
| Net income | -$492.7K | -$13.22M | -$46.90M | -$3.07M |
| EPS (Diluted) | -$0.02 | -$0.45 | -$35.25 | -$0.01 |
| Operating cash flow | -$262.2K | -$9.86M | -$29.14M | -$2.06M |
| Free cash flow | n/a | -$9.96M | -$29.84M | -$2.16M |
| Cash & equivalents | n/a | $3.16M | $11.88M | n/a |
| Total assets | $1.54M | $5.34M | $24.74M | $1.87M |
| Total liabilities | $878.5K | n/a | $4.11M | $206.7K |
| Shareholders' equity | $664.5K | $2.32M | $20.63M | $1.66M |
| Return on year-end equity | -74.2% | -569.1% | -227.3% | -184.6% |
| Shares outstanding | 30.20M | 35.95M | 2.10M | 455.49M |
Revenue, most recent five fiscal years
| Fiscal year | Family Office of America, Inc. | QTREX Quantum Ltd. | Co-Diagnostics, Inc. | Vivos Inc |
|---|---|---|---|---|
| Latest | $221.8K Ended 2025-12-31 | $289.0K Ended 2025-12-31 | $622.5K Ended 2025-12-31 | $68.4K Ended 2025-12-31 |
| 1 year earlier | n/a | $0 Ended 2024-12-31 | $3.92M Ended 2024-12-31 | $28.0K Ended 2024-12-31 |
| 2 years earlier | n/a | $0 Ended 2023-12-31 | $6.81M Ended 2023-12-31 | $19.5K Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $34.22M Ended 2022-12-31 | $36.5K Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $97.89M Ended 2021-12-31 | $14.9K Ended 2021-12-31 |